LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST), a leader in the development and commercialization of anti-infective therapies, today announced the launch of its new CUBICIN product web site at www.cubicin.com. Healthcare providers can go to the site for specific content across a wide range of specialties that include Infectious Diseases, Internal Medicine, Nephrology, Surgery, Oncology, Outpatient and Pharmacy. An educational patient vignette is provided for each specialty, along with product information, prescribing information and an overview of CUBICIN clinical data to date. The site also features content specifically geared towards patients – background on MRSA and information about the Patient Assistance Services Program – that serves to educate and empower patients who are directed to the site by their physician.
